Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Athanasios Dellis

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Expert Opinion on Biological Therapy|March 10, 2017
Stem cell therapy for the treatment of Peyronie's diseaseAthanasios Dellis, Athanasios Papatsoris
Expert Review of Pharmacoeconomics & Outcomes Research|September 6, 2017
Therapeutic outcomes of the LHRH antagonistsAthanasios Dellis, Athanasios Papatsoris
Expert Review of Pharmacoeconomics & Outcomes Research|November 22, 2015
Cost-effectiveness of denosumab as a bone protective agent for patients with castration resistant prostate cancerAthanasios Dellis, Athanasios Papatsoris
Nephro-Urology Monthly|April 11, 2014
Novel optical technology in bladder cancer diagnosis and treatmentAthanasios Dellis, Athanasios Papatsoris
Expert Opinion on Investigational Drugs|April 23, 2014
Intravesical treatment of bladder pain syndrome/interstitial cystitis: from the conventional regimens to the novel botulinum toxin injectionsAthanasios Dellis, Athanasios G Papatsoris
Expert Opinion on Investigational Drugs|March 9, 2016
Phase I and II therapies targeting the androgen receptor for the treatment of castration resistant prostate cancerAthanasios Dellis, Athanasios G Papatsoris
Expert Review of Pharmacoeconomics & Outcomes Research|February 26, 2014
The economics of abiraterone acetate for castration-resistant prostate cancerAthanasios Dellis, Athanasios G Papatsoris
Expert Opinion on Biological Therapy|October 1, 2013
Denosumab as a promising novel bone-targeted agent in castration resistant prostate cancerAthanasios Dellis, Athanasios G Papatsoris
Arab Journal of Urology|November 15, 2019
Bilateral disease and intratesticular haemodynamics as markers of dyspermia in patients with subclinical varicocele: A prospective studyGeorgios Tsampoukas, Athanasios Dellis, Athanasios Papatsoris
Clinical Case Reports|February 16, 2018
Giant genital wartsIoannis Georgopoulos, Constantinos Nastos, Athanasios Dellis
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Expert Opinion on Biological Therapy|March 10, 2017
Stem cell therapy for the treatment of Peyronie's diseaseAthanasios Dellis, Athanasios Papatsoris
Expert Review of Pharmacoeconomics & Outcomes Research|September 6, 2017
Therapeutic outcomes of the LHRH antagonistsAthanasios Dellis, Athanasios Papatsoris
Expert Review of Pharmacoeconomics & Outcomes Research|November 22, 2015
Cost-effectiveness of denosumab as a bone protective agent for patients with castration resistant prostate cancerAthanasios Dellis, Athanasios Papatsoris
Nephro-Urology Monthly|April 11, 2014
Novel optical technology in bladder cancer diagnosis and treatmentAthanasios Dellis, Athanasios Papatsoris
Expert Opinion on Investigational Drugs|April 23, 2014
Intravesical treatment of bladder pain syndrome/interstitial cystitis: from the conventional regimens to the novel botulinum toxin injectionsAthanasios Dellis, Athanasios G Papatsoris
Expert Opinion on Investigational Drugs|March 9, 2016
Phase I and II therapies targeting the androgen receptor for the treatment of castration resistant prostate cancerAthanasios Dellis, Athanasios G Papatsoris
Expert Review of Pharmacoeconomics & Outcomes Research|February 26, 2014
The economics of abiraterone acetate for castration-resistant prostate cancerAthanasios Dellis, Athanasios G Papatsoris
Expert Opinion on Biological Therapy|October 1, 2013
Denosumab as a promising novel bone-targeted agent in castration resistant prostate cancerAthanasios Dellis, Athanasios G Papatsoris
Arab Journal of Urology|November 15, 2019
Bilateral disease and intratesticular haemodynamics as markers of dyspermia in patients with subclinical varicocele: A prospective studyGeorgios Tsampoukas, Athanasios Dellis, Athanasios Papatsoris
Clinical Case Reports|February 16, 2018
Giant genital wartsIoannis Georgopoulos, Constantinos Nastos, Athanasios Dellis
Pageof 9